Clinical Trials Logo

Clinical Trial Summary

In the present study, we hypothesized that primary mode nIPPV initiated shortly after birth would decrease the incidence of intubation or death in twin infants when compared to nCPAP.


Clinical Trial Description

After inclusion of eligible twins infants,one of the twins was supported by nCPAP and another nIPPV. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01926106
Study type Interventional
Source Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Contact
Status Completed
Phase N/A
Start date July 1, 2012
Completion date July 30, 2017

See also
  Status Clinical Trial Phase
Completed NCT02522455 - Flow-cycled Ventilation in Preterm Infants N/A
Not yet recruiting NCT04019886 - Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates N/A
Terminated NCT02999165 - Breastfeeding Infants Receiving Respiratory Support Trial
Completed NCT02112513 - The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
Completed NCT02824497 - Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year
Completed NCT04000568 - Breathing Variability and NAVA in Neonates
Completed NCT02041676 - Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation N/A
Completed NCT02819050 - Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants N/A
Completed NCT02333669 - Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome N/A
Recruiting NCT04409665 - The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST) Phase 1
Completed NCT03446937 - Effect of Antenatal Corticosteroids on Neonatal Morbidity. N/A
Terminated NCT03235986 - A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS) Phase 2
Recruiting NCT06367881 - Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS Phase 1